Finally, in ovarian cancer, enhanced expression of syndecan-1 promotes metastasis by activating mitogen-activated protein kinase, ERK, and phosphatidylinositol (PI)-3 kinase/AKT signaling [29]. This evidence concerns the gene SDC1 and ovarian carcinoma.